1 Min Read
March 19 (Reuters) - Medicure Inc:
* MEDICURE - PLACED PREXXARTAN ORAL SOLUTION PROJECT ON HOLD PENDING RESOLUTION OF DISPUTE BETWEEN OWNER OF NDA, CARMEL BIOSCIENCES, OTHERS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.